|
Real-time Estimate
Cboe BZX
03:59:48 31/10/2026 HKT
|
5-day change | 1st Jan Change | ||
| 119.68 USD | -0.09% |
|
+0.90% | +49.20% |
| 10-20 | Haemonetics Gets FDA Approval for Vascular Closure Device | DJ |
| 10-20 | Haemonetics says FDA clears vascular closure device | RE |
| Market Cap | 5.45B 4.88B 4.49B 4.07B 7.6B 517B 7.75B 53.54B 21.49B 272B 20.45B 20.02B 858B | P/E 2027 * |
30.2x | P/E 2028 * | 26.6x |
|---|---|---|---|---|---|
| Enterprise Value | 6.11B 5.47B 5.04B 4.56B 8.53B 580B 8.69B 60.05B 24.1B 305B 22.94B 22.45B 963B | EV / Sales 2027 * |
4.31x | EV / Sales 2028 * | 3.86x |
| Free-Float |
98.74% | Yield 2027 * |
0.83% | Yield 2028 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| HAE | Delayed | |
CBOE
| HAE | Real-time | |
|
Deutsche Boerse AG
| HAZ | Delayed | |
|
Börse Stuttgart
| HAZ | Delayed | |
|
Boerse Muenchen
| HAZ | Real-time | |
|
Tradegate
| HAZ | Real-time |
Last Transcript: Haemonetics Corporation
| 1 day | -0.18% | ||
| 1 week | +0.90% | ||
| Current month | +13.56% | ||
| 1 month | +13.56% | ||
| 3 months | +40.98% | ||
| 6 months | +99.00% | ||
| Current year | +49.20% |
| 1 week | 117.49 |  | 121.91 |
| 1 month | 101.32 | | 123.77 |
| Current year | 51 | | 123.77 |
| 1 year | 49 | | 123.77 |
| 3 years | 47.32 | | 123.77 |
| 5 years | 43.5 | | 123.77 |
| 10 years | 32.79 | | 142.11 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 62 | 16/05/2016 | |
James D'Arecca
DFI | Director of Finance/CFO | 55 | 11/04/2022 |
Frank Chan
COO | Chief Operating Officer | 56 | 01/04/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Mark Kroll
BRD | Director/Board Member | 73 | 01/01/2006 |
| Director/Board Member | 62 | 16/05/2016 | |
Robert Abernathy
BRD | Director/Board Member | 71 | 18/10/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 24/7/26 | Free | Director | 2,538 | 0.0056% | ||
| 24/7/26 | Free | Director | 2,538 | 0.0056% | ||
| 24/7/26 | Free | Director | 2,538 | 0.0056% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.09% | +0.90% | +139.21% | +40.81% | 5.45B | |
| +1.64% | +2.37% | -14.85% | +14.15% | 181B | |
| -6.44% | -5.01% | -20.93% | +11.11% | 120B | |
| -1.40% | +1.45% | +6.40% | +38.33% | 119B | |
| +3.42% | +1.71% | -42.32% | +9.52% | 91.44B | |
| +0.09% | -0.04% | -3.03% | +78.45% | 63.07B | |
| -0.46% | -0.64% | +9.87% | +80.82% | 55.8B | |
| -0.26% | -0.32% | +10.54% | -21.03% | 54.03B | |
| -4.22% | -1.60% | -12.27% | +39.11% | 45.38B | |
| +0.58% | +2.00% | -1.07% | -6.43% | 34.37B | |
| Average | -0.71% | +0.80% | +7.15% | +28.49% | 76.89B | |
| Weighted average by Cap. | -0.68% | +0.81% | -9.37% | +25.25% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 1.42B 1.27B 1.17B 1.06B 1.98B 135B 2.01B 13.92B 5.59B 70.77B 5.32B 5.2B 223B | 1.5B 1.34B 1.23B 1.12B 2.09B 142B 2.13B 14.69B 5.9B 74.69B 5.61B 5.49B 236B |
| Net income | 177M 159M 146M 132M 248M 16.85B 252M 1.74B 700M 8.86B 666M 652M 27.95B | 207M 186M 171M 155M 289M 19.68B 295M 2.04B 817M 10.35B 778M 761M 32.64B |
| Net Debt | 662M 593M 545M 494M 924M 62.86B 941M 6.5B 2.61B 33.07B 2.48B 2.43B 104B | 327M 293M 269M 244M 456M 31.06B 465M 3.21B 1.29B 16.34B 1.23B 1.2B 51.53B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 31/10/26 | US$119.69 | -0.09% | 294,784 |
| 29/10/26 | US$119.79 | +1.24% | 558,543 |
| 28/10/26 | US$118.32 | -1.38% | 501,823 |
| 27/10/26 | US$119.97 | +0.65% | 900,886 |
| 26/10/26 | US$119.19 | +0.57% | 469,737 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- HAE Stock
Select your edition
All financial news and data tailored to specific country editions
